We are excited to announce the merger of Selecta Biosciences and Cartesian Therapeutics to create a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease. Please follow us on our new page Cartesian Therapeutics to continue to follow the story and receive updates on our progress. For more information on the merge, click here: https://lnkd.in/eMqMPj3M
